Ron Spivey has over 35 years of experience in the pharmaceutical industry, working in a wide variety of technical areas of pharmaceutical development. He has held key positions in large multinational companies (Parke-Davis, Burroughs Wellcome Company, Marion Merrell Dow), generic companies (Ivax/Zenith Goldline Pharmaceuticals, Purepac/Alpharma) and entrepreneurial companies (Acura Pharmaceuticals Inc., Cima Labs Inc.).
Spivey has in-depth experience and knowledge related to the overall drug development process. During his career, he managed multiple scientific disciplines including pharmaceutical development, analytical development, clinical development, statistics, quality assurance, quality control and regulatory compliance. He has been actively involved in managing the development, submission and approval of more than 30 branded and generic pharmaceutical products.
Spivey received his PhD in Pharmaceutics from the University of Iowa in 1976 and his Bachelor’s degree in Zoology from Indiana University in 1970.